Largest single vaccine donation reaches Islamabad
International Health Partners says that the donation it has just received from Baxter International of 280,000 doses of NEISVAC meningitis vaccines arrived in Islamabad, Pakistan, on March 11. The medicines have a UK wholesale value of L5.2 million ($9.1 million).
This is the largest single donation of medicines from the UK to a disaster situation. These vaccines form part of a program of aid for Kashmir being organized by IHP on behalf of the medical community, non-governmental organizations, government and the pharmaceutical industry in the UK. IHP has been liaising closely with the joint emergency coordinating team of the World Health Organization and Pakistan Ministry of Health to develop a program of donated vaccines, medicines and medical supplies to support the relief effort in Kashmir.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze